Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
For upcoming studies, it would be important to identify any potential high-risk subgroups as well as assess whether the elevated risk of NAION is a drug class effect or a specific finding for subcutaneously administered semaglutide. 12.02.24 MDL cases continued to grow in December The GLP-1 MDL continued to grow, bringing the total number of cases in the docket to 1,300
The clinical relationship is strong too: You see the same provider every time, and the level of detail in my consultation was the best Ive experienced across all clinics Ive reviewed
April 1, 2026: More Lawsuits Join Vision Loss MDL for GLP-1 Drugs, Like Ozempic As of April 1, 2026, there are 73 pending lawsuits in the centralized litigation for people alleging NAION from GLP-1 drugs, including Ozempic
They can if enrolled in a standalone Part D prescription drug plan, Medicare Advantage plan or any other plan that includes Part D drug coverage
US$ 25.84
US$ 28.93
US$ 21.60
US$ 26.19
US$ 20.83
US$ 27.66
US$ 20.53
US$ 20.80
US$ 20.43
US$ 26.90
US$ 23.98
